CSL Limited (CMXHF)
CMXHF Stock Price Chart
Explore CSL Limited interactive price chart. Choose custom timeframes to analyze CMXHF price movements and trends.
CMXHF Company Profile
Discover essential business fundamentals and corporate details for CSL Limited (CMXHF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Nov 2005
Employees
32.70K
Website
https://www.csl.com.auCEO
Paul F. McKenzie
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
CMXHF Financial Timeline
Browse a chronological timeline of CSL Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 8 Feb 2026
Dividend declared on 19 Aug 2025
A dividend of $1.62 per share was announced, adjusted to $1.62. The dividend will be paid on 3 Oct 2025.
Earnings released on 18 Aug 2025
EPS came in at $1.38 falling short of the estimated $2.62 by -47.33%, while revenue for the quarter reached $4.74B , missing expectations by -34.02%.
Earnings released on 11 Feb 2025
EPS came in at $2.56 falling short of the estimated $4.41 by -41.95%, while revenue for the quarter reached $5.08B , missing expectations by -40.46%.
Dividend declared on 11 Feb 2025
A dividend of $1.30 per share was announced, adjusted to $1.31. The dividend was paid on 9 Apr 2025.
Earnings released on 13 Aug 2024
EPS came in at $1.83 surpassing the estimated $1.80 by +1.67%, while revenue for the quarter reached $4.50B , missing expectations by -32.12%.
Dividend declared on 13 Aug 2024
A dividend of $1.45 per share was announced, adjusted to $1.47. The dividend was paid on 2 Oct 2024.
Earnings released on 11 Apr 2024
EPS came in at $2.78 falling short of the estimated $4.07 by -31.70%, while revenue for the quarter reached $5.69B , missing expectations by -28.29%.
Dividend declared on 13 Feb 2024
A dividend of $1.19 per share was announced, adjusted to $1.19. The dividend was paid on 3 Apr 2024.
Dividend declared on 15 Aug 2023
A dividend of $1.29 per share was announced, adjusted to $1.35. The dividend was paid on 4 Oct 2023.
Earnings released on 30 Jun 2023
EPS came in at $0.82 falling short of the estimated $1.67 by -51.14%, while revenue for the quarter reached $3.94B , missing expectations by -35.96%.
Dividend declared on 14 Feb 2023
A dividend of $1.07 per share was announced, adjusted to $1.07. The dividend was paid on 5 Apr 2023.
Earnings released on 30 Dec 2022
EPS came in at $2.36 falling short of the estimated $3.50 by -32.57%, while revenue for the quarter reached $4.97B , missing expectations by -27.92%.
Dividend declared on 17 Aug 2022
A dividend of $1.18 per share was announced, adjusted to $1.23. The dividend was paid on 5 Oct 2022.
Earnings released on 30 Jun 2022
EPS came in at $0.63 falling short of the estimated $1.09 by -42.29%, while revenue for the quarter reached $2.96B , missing expectations by -36.52%.
Dividend declared on 16 Feb 2022
A dividend of $1.04 per share was announced, adjusted to $1.05. The dividend was paid on 6 Apr 2022.
Earnings released on 30 Dec 2021
EPS came in at $2.76 falling short of the estimated $3.40 by -18.82%, while revenue for the quarter reached $4.32B , missing expectations by -26.18%.
Dividend declared on 18 Aug 2021
A dividend of $1.18 per share was announced, adjusted to $1.23. The dividend was paid on 30 Sept 2021.
Earnings released on 30 Jun 2021
EPS came in at $0.61 falling short of the estimated $1.09 by -43.85%, while revenue for the quarter reached $2.26B , missing expectations by -49.18%.
Dividend declared on 18 Feb 2021
A dividend of $1.04 per share was announced, adjusted to $1.04. The dividend was paid on 1 Apr 2021.
Earnings released on 30 Dec 2020
EPS came in at $2.13 falling short of the estimated $3.12 by -31.73%, while revenue for the quarter reached $3.07B , missing expectations by -44.63%.
Dividend declared on 19 Aug 2020
A dividend of $1.07 per share was announced, adjusted to $1.07. The dividend was paid on 9 Oct 2020.
CMXHF Stock Performance
Access detailed CMXHF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.